eMedicine Specialties > Neurosurgery > Neoplasm

Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms: Treatment

Author: James S Harrop, MD, Associate Professor, Departments of Neurological and Orthopedic Surgery, Jefferson Medical College
Coauthor(s): Ashwini D Sharan, MD, Assistant Professor of Neurosurgery, Assistant Professor of Neurology, Thomas Jefferson University School of Medicine
Contributor Information and Disclosures

Updated: May 27, 2009

Treatment

Medical Therapy

Pharmacological treatment of intramedullary spinal cord tumors is of limited benefit. High-dose intravenous corticosteroid therapy may improve neurologic function transiently but is not appropriate for long-term treatment. Although steroids decrease vasogenic edema, they do not treat the underlying pathologic condition. Prolonged use of steroids can be associated with gastric ulceration, hyperglycemia, and immunosuppression with cushingoid features.

Chemotherapeutic regimens have limited success in the treatment of spinal cord neoplasms. This may be partly due to the inability of the chemotactic agents to cross the blood-brain barrier.

Standard fractionated radiation is used for astrocytomas of residual and recurrent neoplasm. 

Stereotactic spinal radiosurgery may be helpful for treating these lesions. Although similar symptomatic control may be achieved over the short term when compared with surgical resection, recurrence and malignant tumor transformation have been observed after radiotherapy. This treatment may be most effective in dealing with malignant lesions only. In the future, stereotactic or intensity-modulated radiosurgery may play larger role in treatment options available for patients. Because of the precision with which the radiation is delivered, radiosurgery helps to minimize spinal cord radiation toxicity and/or necrosis.

Surgical Therapy

Patients presenting with neurologic deficits and mass lesions in the spinal cord require histopathology in order to define the neoplasm such that treatment options can be maximized. The surgical approach to these lesions typically consists of preparing for gross total resection. The neoplasm is identified and then biopsy is performed. Surgery then proceeds based on the histology from the frozen specimen as well as the ability to define a surgical plane to resect the lesion. If the lesion is an astrocytoma, then the goal is debulking the tumor while not injuring the normal neural tracts.  Ependymomas are attempted to be resected completely as long as a viable plane can be established and normal neural tracts are not disturbed.

Preoperative Details

Any patient suspected of having an intrinsic spinal cord neoplasm should undergo a detailed history and physical examination. The preoperative evaluation should consist of a detailed neurologic examination and appropriate imaging studies to confirm the diagnosis. Detailed imaging studies should consist of MRI with and without gadolinium. If MRI is not available, myelography with CT scanning should be used. If appropriate, obtain a preoperative medical evaluation.

Intraoperative Details

Surgical resection is performed with the patient under general anesthesia, typically in a prone position. Intraoperative neurophysiological monitoring provides real-time feedback regarding possible ischemia or retraction injury to the spinal cord during the resection and is used by some surgeons.

A laminectomy (laminoplasty in children) is performed after radiographic confirmation of the appropriate spinal level. The laminectomy defect should be of sufficient size to allow visualization of healthy spinal cord above and below the suspected neoplasm.

Some patients have a kyphosis (curve) or straightening of the spine and removing the laminae can cause further progression of this curve.  Therefore, some surgeons opt to fuse (arthrodesis) the spine over the area the laminectomy is performed to prevent it from bending forward further. 

The dura mater is exposed at the correct levels. An intraoperative ultrasound study can be used to confirm adequate bony decompression and the lesion is center prior to the dural opening. Intraoperative ultrasound can also reveal the extent of the lesion and the degree of resection. The dura mater is incised or opened in the midline and then secured laterally to maintain the exposure.

Using the intraoperative microscope or magnification, the spinal cord is inspected and the pia mater is opened directly over the tumor exposing the spinal cord. The spinal cord is incised sharply typically through the midline raphe. Once the tumor is exposed, a plane is established at the periphery.

A biopsy specimen is obtained from the center of the lesion and sent for histopathological analysis. If pathologic evaluation confirms a low-grade neoplasm, the median exposure is opened until the full extent of the intraparenchymal lesion can be visualized. The dissection plane is further developed between the tumor and the normal spinal cord parenchyma. Often, cystic cavities help define the caudal and rostral margins of the tumor. Ependymomas tend to be encapsulated, brownish-red, sausage-shaped masses, whereas astrocytomas are ill-defined, whitish enlargements with associated cysts.

The goal for benign or low-grade neoplasms is gross total resection. Once the tumor-spinal cord interface is defined, the tumor can be debulked internally with gentle dissection or an ultrasonic cavitation to reduce spinal cord manipulation. Complete resection of benign neoplasms cannot always be achieved without neurological injury, particularly if the tumor–spinal cord interface is indistinct.

Patients with biopsy-proven high-grade lesions typically have a rapid progression in neurological dysfunction, even after aggressive resections. Consequently, only biopsy and a dural patch graft (to enlarge the space for the spinal cord) may be an alternate approach to attempted resection. When surgical resection is completed, the dura and muscles are closed in layers.

Postoperative Details

Patients are closely monitored in an ICU setting to monitor their neurologic examination and acutely detect and neurologic deterioration. Incisional pain should be minimal and should be relieved with intravenous analgesics. Patients typically have some degree of posterior column dysfunction due to traction and manipulation during surgery. This usually is in the form of "numbness" below the region of resection as well as proprioception difficulty. The proprioception difficulties can be disabling for the patients because they impair ambulation and fine motor control. These deficits tend to progressively improve with time. In Brotchi's series of 239 patients with low-grade spinal tumors, 5% of patients worsened, 50% of patients stabilized, and 40% of patients improved after surgical intervention.1 Overall, patients typically maintained their preoperative level of function postoperatively.

Depending on the needs of patients, they are either discharged home or transferred to a rehabilitation facility.

Follow-up

Follow-up care should include serial neurologic examinations and MRI to monitor for recurrence or progressive growth of residual tumor. If patients experience any neurologic worsening, perform contrast-enhanced MRI. The recurrence rate for low-grade tumors is less than 5%; approximately 10% of patients have progression of residual tumor.

Consider radiotherapy or stereotactic radiosurgery for the treatment of malignant neoplasms. Its role in benign neoplasms is unclear, but, typically, serial observation is recommended.

Complications

  • Bladder and bowel dysfunction
  • Bleeding or hematoma
  • Cerebrospinal fluid leak
  • Chronic pain
  • Injury to central nervous system tissue
  • Meningitis
  • Paralysis
  • Sensory loss
  • Sexual dysfunction
  • Skin infection or cellulitis
  • Spine instability
  • Ventilator dependence and death
  • Wound dehiscence

More on Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms

Overview: Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms
Workup: Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms
Treatment: Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms
Follow-up: Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms
Multimedia: Spinal Cord Tumors - Management of Intradural Intramedullary Neoplasms
References

References

  1. Brotchi J. Intrinsic spinal cord tumor resection. Neurosurgery. May 2002;50(5):1059-63. [Medline].

  2. Burger PC, Scheithauer BW. Tumors of the central nervous system. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. 3rd series, fasc 10. Washington, DC: Armed Forces Institute of Pathology; 1994.

  3. Casha S, Phan N, Rutka JT. Spinal Cord and Column Tumors in Children. Spinal Cord and Spinal Column Tumors - Thieme. 2006;1:187-203.

  4. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg. Oct 2000;93(2 Suppl):183-93. [Medline].

  5. Cooper PR, Hida K. Intramedullary Spinal Cord Tumors. Spinal Cord and Spinal Column Tumors - Thieme. 2006;315-334.

  6. Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. Sep 1992;77(3):355-9. [Medline].

  7. Kane PJ, el-Mahdy W, Singh A, Powell MP, Crockard HA. Spinal intradural tumours: Part II--Intramedullary. Br J Neurosurg. Dec 1999;13(6):558-63. [Medline].

  8. Mechtler L, Cohen ME. Clinical presentation and therapy of spinal tumors. In: Bradley, WG, Daroff RB, Fenchel GM, Marsden CD. Neurology in Clinical Practice: The Neurological Disorders. 2nd ed. Boston, Mass: Butterworth-Heinemann; 1996.

  9. Osborn AG. Diagnostic Neuroradiology. St. Louis, Mo: Mosby-Year Book; 1994.

  10. Parsa AT, Lee J, Parney IF, Weinstein P, McCormick PC, Ames C. Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J Neurooncol. Aug-Sep 2004;69(1-3):291-318. [Medline].

  11. Sahni D, Harrop JS, Kalfas IH, Vaccaro AR, Weingarten D. Exophytic intramedullary meningioma of the cervical spinal cord. J Clin Neurosci. Oct 2008;15(10):1176-9. [Medline].

  12. Saraceni C, Harrop JS. Spinal meningioma: chronicles of contemporary neurosurgical diagnosis and management. Clin Neurol Neurosurg. Apr 2009;111(3):221-6. [Medline].

  13. Simeone FA. Intradural tumors. In: Rothman RH, Simeone FA, eds. The Spine. 3rd ed. Philadelphia, Pa: WB Saunders; 1992.

  14. Slin'ko EI, Al-Qashqish II. Intradural ventral and ventrolateral tumors of the spinal cord: surgical treatment and results. Neurosurg Focus. Jul 15 2004;17(1):ECP2. [Medline].

  15. Manzano G, Green BA, Vanni S, Levi AD. Contemporary management of adult intramedullary spinal tumors-pathology and neurological outcomes related to surgical resection. Spinal Cord. Aug 2008;46(8):540-6. [Medline].

Further Reading

Keywords

spinal cord tumors, spinal tumors, spinal cord neoplasms, spinal neoplasms, intramedullary spinal cord tumor, intradural neoplasms, intradural tumors, intramedullary neoplasms, spine tumors, glial cell neoplasms, glial cell tumors, astrocytomas, ependymomas, hemangioblastomas, paragangliomas, oligodendrogliomas, gangliogliomas, schwannomas, meningiomas, neurofibromas, intradural intramedullary neoplasms

Contributor Information and Disclosures

Author

James S Harrop, MD, Associate Professor, Departments of Neurological and Orthopedic Surgery, Jefferson Medical College
James S Harrop, MD is a member of the following medical societies: American Association of Neurological Surgeons, American College of Surgeons, American Spinal Injury Association, Cervical Spine Research Society, Congress of Neurological Surgeons, and North American Spine Society
Disclosure: Depuy spine Consulting fee Consulting; Medtronic Consulting fee Consulting; stryker spine Honoraria Speaking and teaching

Coauthor(s)

Ashwini D Sharan, MD, Assistant Professor of Neurosurgery, Assistant Professor of Neurology, Thomas Jefferson University School of Medicine
Ashwini D Sharan, MD is a member of the following medical societies: American Medical Association, Association for the Advancement of Medical Instrumentation, Congress of Neurological Surgeons, and Movement Disorders Society
Disclosure: Nothing to disclose.

Medical Editor

Scott C Dulebohn, MD, Neurological Surgeon, Appalachian Neurosurgical
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.